Emily Gouker
Medical · Mishawaka, INNPI 1447922638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 343 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,999 and has fallen 72.0% since, to $841 in 2025. Among medical clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 343 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$832
- Novo Nordisk$621
- AstraZeneca$577
- Lilly USA, LLC$498
- Bayer$418
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,02099%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $1,519 |
| Amgen | 26 | $832 |
| Novo Nordisk | 29 | $621 |
| AstraZeneca | 22 | $577 |
| Lilly USA, LLC | 29 | $498 |
| Bayer | 14 | $418 |
| Boehringer Ingelheim | 14 | $231 |
| Pfizer | 6 | $220 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $212 |
| Esperion Therapeutics, Inc. | 7 | $202 |
| Sanofi-aventis U.S. LLC | 11 | $187 |
| Otsuka America Pharmaceutical, Inc. | 9 | $175 |
| Teva Pharmaceuticals USA, Inc. | 9 | $168 |
| GSK | 10 | $153 |
| Grifols USA, LLC | 6 | $126 |
| Astellas Pharma US Inc | 4 | $125 |
| Novartis | 7 | $111 |
| Insulet Corporation | 7 | $97 |
| Paratek Pharmaceuticals, Inc. | 5 | $95 |
| Lundbeck LLC | 5 | $76 |
| Dexcom, Inc. | 4 | $57 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Nestle Healthcare Nutrition Inc. | 1 | $50 |
| Galderma Laboratories, L.p. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 1 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Mylan Specialty L.p. | 1 | $23 |
| Ardelyx, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Exact Sciences | 1 | $15 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,086 in reported general payments places this provider in the 90th percentile of 273 medical providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 11 | $106 |
Paid to pharmacies, not to this prescriber.
Other medical in Mishawaka
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Brandon BoydCarmel$46K
- Karey DavisNew Castle$45K
- Sheryl NewCarmel$39K
- Lindsey GradyValparaiso$39K
- Jennifer IrwinIndianapolis$34K
- Dennae DaltonZionsville$33K
- Jenifer FortneyFort Wayne$26K
- Jordan Stemer-MirandaCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.